Market Rank #5 · Evidence Tier A

Canada
Neuroscience Intelligence

Canada neuroscience intelligence: 510 indexed trials, 298 institutions, research score 50.86.

⚗
510Indexed trials
↗
129Recruiting
⌂
298Research institutions
◎
50.9Research score

Evidence profile

224Sponsors
31Disease areas
0Institution works
0Institution citations

Evidence signals

Research score 50.9 · Data confidence 100.00 · Evidence 50.9

Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.

Leading disease areas

alzheimers92trials
parkinsons86trials
depression48trials
epilepsy36trials
autism28trials
stroke26trials
other_neurology24trials
adhd23trials
multiple_sclerosis21trials
pain_neuropathy18trials

Leading indexed sponsors

Merck Sharp & Dohme LLC26trials
University of Calgary18trials
Hoffmann-La Roche16trials
Centre for Addiction and Mental Health14trials
Sunnybrook Health Sciences Centre11trials
Eli Lilly and Company10trials
Pfizer10trials
University of Manitoba10trials
University Health Network, Toronto9trials
McMaster University9trials